• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

恶性胸膜间皮瘤：时间紧迫。

Malignant Pleural Mesothelioma: Time Is Running Out.

作者信息

Lococo Filippo

机构信息

Università Cattolica del Sacro Cuore, 20123 Rome, Italy.

Thoracic Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

出版信息

J Clin Med. 2021 Feb 8;10(4):648. doi: 10.3390/jcm10040648.

DOI:10.3390/jcm10040648
PMID:33567623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7914895/
Abstract

Malignant pleural mesothelioma (MPM) is a rare but highly malignant disease of the pleura usually related to asbestos exposure [...].

摘要

恶性胸膜间皮瘤（MPM）是一种罕见但恶性程度很高的胸膜疾病，通常与接触石棉有关[...]。

相似文献

1
Malignant Pleural Mesothelioma: Time Is Running Out.恶性胸膜间皮瘤：时间紧迫。
J Clin Med. 2021 Feb 8;10(4):648. doi: 10.3390/jcm10040648.
2
Non-asbestos-related malignant pleural mesothelioma.非石棉相关的恶性胸膜间皮瘤
Intern Med. 2014;53(17):1977-9. doi: 10.2169/internalmedicine.53.0900. Epub 2014 Sep 1.
3
Clinical and prognostic features of erionite-induced malignant mesothelioma.毛沸石诱发的恶性间皮瘤的临床和预后特征。
Yonsei Med J. 2015 Mar;56(2):311-23. doi: 10.3349/ymj.2015.56.2.311.
4
Malignant Mesothelioma Versus Metastatic Carcinoma of the Pleura: A CT Challenge.恶性间皮瘤与胸膜转移性癌：CT诊断难题
Iran J Radiol. 2016 Jan 14;13(1):e10949. doi: 10.5812/iranjradiol.10949. eCollection 2016 Jan.
5
An Overview of Asbestos and Malignant Pleural Mesothelioma: An Iranian Perspective.石棉与恶性胸膜间皮瘤概述：伊朗视角
Asian Pac J Cancer Prev. 2017 Oct 26;18(10):2619-2623. doi: 10.22034/APJCP.2017.18.10.2619.
6
Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.外周血 DNA 甲基化作为石棉暴露人群恶性胸膜间皮瘤的潜在生物标志物。
J Thorac Oncol. 2019 Mar;14(3):527-539. doi: 10.1016/j.jtho.2018.10.163. Epub 2018 Nov 5.
7
Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.骨桥蛋白和血清间皮素在恶性胸膜间皮瘤诊断及预后评估中的应用价值。
Clin Cancer Res. 2007 May 15;13(10):2928-35. doi: 10.1158/1078-0432.CCR-06-2144.
8
Computed tomography findings in 66 patients with malignant pleural mesothelioma due to environmental exposure to asbestos.66例因环境暴露于石棉而患恶性胸膜间皮瘤患者的计算机断层扫描结果。
Clin Imaging. 2006 May-Jun;30(3):177-80. doi: 10.1016/j.clinimag.2005.12.027.
9
CT findings in malignant pleural mesothelioma related to nonoccupational exposure to asbestos and fibrous zeolite (erionite).与非职业性接触石棉和纤维沸石（毛沸石）相关的恶性胸膜间皮瘤的CT表现
J Comput Assist Tomogr. 1991 Mar-Apr;15(2):256-60. doi: 10.1097/00004728-199103000-00012.
10
Pleural Mesothelioma with No Asbestos Exposure: A Case Report.无石棉暴露史的胸膜间皮瘤：一例报告
J Clin Diagn Res. 2016 Nov;10(11):OD07-OD08. doi: 10.7860/JCDR/2016/21066.8849. Epub 2016 Nov 1.

引用本文的文献

1
Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.同时靶向血管内皮生长因子受体2（VEGFR2）和程序性死亡受体配体1（PD-L1）可促进胸膜间皮瘤的存活和血管正常化。
Oncoimmunology. 2025 Dec;14(1):2512104. doi: 10.1080/2162402X.2025.2512104. Epub 2025 May 29.
2
Single-Center 20-Year Experience in Surgical Treatment of Malignant Pleural Mesothelioma.单中心20年恶性胸膜间皮瘤外科治疗经验
J Clin Med. 2022 Aug 3;11(15):4537. doi: 10.3390/jcm11154537.
3
The Prognostic Value of F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review.F-FDG PET成像在恶性胸膜间皮瘤患者分期中的预后价值：文献综述
J Clin Med. 2021 Dec 22;11(1):33. doi: 10.3390/jcm11010033.

本文引用的文献

1
Burden of Mesothelioma Deaths by National Income Category: Current Status and Future Implications.按国民收入类别划分的间皮瘤死亡负担：现状和未来影响。
Int J Environ Res Public Health. 2020 Sep 21;17(18):6900. doi: 10.3390/ijerph17186900.
2
Deep Sequencing Analysis Identified a Specific Subset of Mutations Distinctive of Biphasic Malignant Pleural Mesothelioma.深度测序分析确定了双相性恶性胸膜间皮瘤特有的特定突变子集。
Cancers (Basel). 2020 Aug 29;12(9):2454. doi: 10.3390/cancers12092454.
3
Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural Mesotheliomas.恶性胸膜间皮瘤患者中 DNA 损伤修复相关种系新突变。
J Thorac Oncol. 2020 Apr;15(4):655-660. doi: 10.1016/j.jtho.2019.12.111. Epub 2019 Dec 28.
4
Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.双相恶性胸膜间皮瘤患者的生存结果：一项多中心分析。
J Thorac Cardiovasc Surg. 2020 Apr;159(4):1584-1593.e2. doi: 10.1016/j.jtcvs.2019.08.027. Epub 2019 Sep 9.
5
Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.使用常规临床参数对接受细胞减灭术的恶性胸膜间皮瘤患者进行分层以预测生存。
J Thorac Oncol. 2019 Feb;14(2):288-293. doi: 10.1016/j.jtho.2018.10.005. Epub 2018 Oct 24.
6
Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications.恶性胸膜间皮瘤发病和进展的异质影响因素：生物学进展及临床意义。
Int J Mol Sci. 2018 Jan 13;19(1):238. doi: 10.3390/ijms19010238.
7
Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.使用生物标志物对间皮瘤进行预后评估和监测：一项系统综述
Br J Cancer. 2017 Mar 14;116(6):731-741. doi: 10.1038/bjc.2017.22. Epub 2017 Feb 7.
8
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.胸膜外全肺切除术与非胸膜外全肺切除术治疗恶性胸膜间皮瘤患者的比较：间皮瘤和根治性手术（MARS）随机可行性研究的临床结果。
Lancet Oncol. 2011 Aug;12(8):763-72. doi: 10.1016/S1470-2045(11)70149-8. Epub 2011 Jun 30.
9
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.欧洲呼吸学会和欧洲胸外科协会关于恶性胸膜间皮瘤管理的指南。
Eur Respir J. 2010 Mar;35(3):479-95. doi: 10.1183/09031936.00063109. Epub 2009 Aug 28.
10
Malignant mesothelioma.恶性间皮瘤
Lancet. 2005;366(9483):397-408. doi: 10.1016/S0140-6736(05)67025-0.